Covidien taps Almeida as its next CEO

Covidien announced this morning that President and CEO Richard Meelia intends to retire effective July 1, and Joe Almeida, current president of Covidien's Medical Devices business segment, has been elected to succeed him. Meelia will serve as non-executive chairman of the board for a transition period of up to one year following his retirement as CEO, according to a release.

Meelia was elected president and CEO of Covidien when the business, then known as Tyco Healthcare, spun off from parent company Tyco International in June 2007. He was selected as chairman of the board in October 2008. "Rich Meelia has been a strong and highly effective leader, and his service as CEO is deeply appreciated," said Timothy Donahue, lead director on the company's board. "Under his leadership, Covidien has introduced a record number of innovative new products, realigned and strengthened its portfolio, significantly reduced costs, developed a deep bench of management talent and created increased value for shareholders."

Almeida joined Tyco Healthcare in 1995, and became head of Medical Devices in October 2006. The device unit accounts for about two-thirds of Covidien's total annual revenue and three-quarters of its operating profit.

- check out the Covidien release

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.